Potential binding sites containing nine residues derived from binding site similarity searches
DrReposER ID
Hit
Organism / Macromolecule
Interface
HETATM
RMSD
Dali Z-score
Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 113HIS A 115HIS A 117HIS A 135VAL A 137LEU A 216THR A 217THR A 218TRP A 227
None ZN A 283 ( 3.2A) ZN A 283 (-3.2A) ZN A 283 ( 3.1A)ACY A 279 ( 4.7A)ACY A 279 (-4.3A)ACY A 279 (-3.4A)ACY A 279 ( 4.9A)None
0.38A
1jd0A-1y7wA:24.7
1jd0A-1y7wA:29.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 161HIS A 163HIS A 165HIS A 182VAL A 184LEU A 259THR A 260THR A 261TRP A 270
None ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNone ZN A 378 ( 4.5A)NoneNone
0.44A
1jd0A-3b1bA:24.8
1jd0A-3b1bA:26.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 121HIS A 123HIS A 125HIS A 142VAL A 144LEU A 214THR A 215THR A 216TRP A 225
MLT A 3 (-3.9A) ZN A 1 ( 3.2A) ZN A 1 (-3.3A) ZN A 1 ( 3.2A)NoneMLT A 3 ( 4.2A)MLT A 3 ( 4.3A)MLT A 3 (-2.8A)MLT A 3 (-4.9A)
0.50A
1jd0A-3q31A:24.7
1jd0A-3q31A:26.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 87HIS A 89HIS A 91HIS A 108VAL A 110LEU A 173THR A 174THR A 175TRP A 184
AZM A 302 (-4.4A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)AZM A 302 (-4.7A)AZM A 302 (-3.8A)AZM A 302 (-3.4A)AZM A 302 (-3.4A)None
0.42A
1jd0A-4g7aA:30.3
1jd0A-4g7aA:27.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 158HIS A 160HIS A 162HIS A 179VAL A 181LEU A 253THR A 254THR A 255TRP A 264
None ZN A 401 ( 3.2A) ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)None2HP A 402 (-3.4A)2HP A 402 (-2.9A)2HP A 402 (-3.6A)None
0.44A
1jd0A-4xixA:25.3
1jd0A-4xixA:29.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 115HIS A 117HIS A 119HIS A 136VAL A 138LEU A 201THR A 202THR A 203TRP A 212
None ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNone ZN A 301 (-4.4A)NoneNone
0.42A
1jd0A-6ekiA:29.5
1jd0A-6ekiA:15.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 92HIS A 94HIS A 96HIS A 119VAL A 121LEU A 198THR A 199THR A 200TRP A 209
V14 A 302 (-3.8A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)V14 A 302 (-3.6A)V14 A 302 (-3.2A)V14 A 302 (-3.5A)None
0.42A
1jd0A-6fe1A:37.3
1jd0A-6fe1A:15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 135ASP A 146LEU A 162VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216
RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None
0.60A
1q6iA-1pbkA:15.7
1q6iA-1pbkA:25.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.36A
1zw5A-1rqjA:30.4
1zw5A-1rqjA:27.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.51A
1zw5A-3q1oA:31.3
1zw5A-3q1oA:26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.44A
1zw5A-6b07A:47.4
1zw5A-6b07A:14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156LYS A 244THR A 245TYR A 248GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)NoneC6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.41A
2f89F-6b07A:47.7
2f89F-6b07A:14.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.39A
3ez3A-1rqjA:29.3
3ez3A-1rqjA:24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.47A
3ez3A-3q1oA:31.0
3ez3A-3q1oA:26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264
MG A 403 (-2.5A) MG A 403 (-2.4A)0MW A 404 (-2.7A)0MW A 404 (-3.7A)0MW A 404 (-2.8A)IPE A 405 ( 4.6A)0MW A 404 ( 3.8A) MG A 401 (-2.7A)0MW A 404 ( 3.0A)
0.57A
3ez3A-4e1eA:45.1
3ez3A-4e1eA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.50A
3ez3A-6b07A:43.4
3ez3A-6b07A:12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.32A
3ez3B-1rqjA:29.1
3ez3B-1rqjA:24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.45A
3ez3B-3q1oA:30.3
3ez3B-3q1oA:26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264
MG A 403 (-2.5A) MG A 403 (-2.4A)0MW A 404 (-2.7A)0MW A 404 (-3.7A)0MW A 404 (-2.8A)IPE A 405 ( 4.6A)0MW A 404 ( 3.8A) MG A 401 (-2.7A)0MW A 404 ( 3.0A)
0.46A
3ez3B-4e1eA:44.3
3ez3B-4e1eA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.45A
3ez3B-6b07A:42.8
3ez3B-6b07A:12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.37A
3ez3C-1rqjA:29.3
3ez3C-1rqjA:24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.48A
3ez3C-3q1oA:30.9
3ez3C-3q1oA:26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264
MG A 403 (-2.5A) MG A 403 (-2.4A)0MW A 404 (-2.7A)0MW A 404 (-3.7A)0MW A 404 (-2.8A)IPE A 405 ( 4.6A)0MW A 404 ( 3.8A) MG A 401 (-2.7A)0MW A 404 ( 3.0A)
0.56A
3ez3C-4e1eA:45.1
3ez3C-4e1eA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.50A
3ez3C-6b07A:43.4
3ez3C-6b07A:12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9VAL A 42HIS A 45MET A 132ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.5A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.56A
3fhjD-6dfuA:39.1
3fhjD-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9VAL A 42HIS A 45MET A 132ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.5A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.56A
3fhjF-6dfuA:39.7
3fhjF-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.86A
3fi0A-6dfuA:38.9
3fi0A-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.86A
3fi0C-6dfuA:39.2
3fi0C-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.88A
3fi0K-6dfuA:38.7
3fi0K-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.83A
3fi0L-6dfuA:39.9
3fi0L-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.87A
3fi0N-6dfuA:39.7
3fi0N-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.82A
3fi0O-6dfuA:39.6
3fi0O-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 218ASP A 220ASN A 222SER A 229HIS A 233GLY A 234ASP A 274GLU A 277THR A 337
MN A 412 ( 3.3A)FB6 A 414 ( 2.6A)FB6 A 414 (-4.0A)FB6 A 414 (-2.6A)FB6 A 414 (-3.5A)FB6 A 414 (-3.6A)FB6 A 414 (-2.9A)FB6 A 414 ( 4.0A)FB6 A 414 ( 4.2A)
0.40A
3gn0A-3sl1A:44.6
3gn0A-3sl1A:29.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 218ASP A 220ASN A 222SER A 229HIS A 233GLY A 234ASP A 274GLU A 277THR A 337
MN A 412 ( 3.3A)FB6 A 414 ( 2.6A)FB6 A 414 (-4.0A)FB6 A 414 (-2.6A)FB6 A 414 (-3.5A)FB6 A 414 (-3.6A)FB6 A 414 (-2.9A)FB6 A 414 ( 4.0A)FB6 A 414 ( 4.2A)
0.40A
3gn0B-3sl1A:44.9
3gn0B-3sl1A:29.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.37A
3ldwA-1rqjA:29.1
3ldwA-1rqjA:24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.49A
3ldwA-3q1oA:30.9
3ldwA-3q1oA:26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264
MG A 403 (-2.5A) MG A 403 (-2.4A)0MW A 404 (-2.7A)0MW A 404 (-3.7A)0MW A 404 (-2.8A)IPE A 405 ( 4.6A)0MW A 404 ( 3.8A) MG A 401 (-2.7A)0MW A 404 ( 3.0A)
0.58A
3ldwA-4e1eA:45.0
3ldwA-4e1eA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.50A
3ldwA-6b07A:43.4
3ldwA-6b07A:12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.32A
3ldwB-1rqjA:29.1
3ldwB-1rqjA:24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.47A
3ldwB-3q1oA:30.2
3ldwB-3q1oA:26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264
MG A 403 (-2.5A) MG A 403 (-2.4A)0MW A 404 (-2.7A)0MW A 404 (-3.7A)0MW A 404 (-2.8A)IPE A 405 ( 4.6A)0MW A 404 ( 3.8A) MG A 401 (-2.7A)0MW A 404 ( 3.0A)
0.47A
3ldwB-4e1eA:44.4
3ldwB-4e1eA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.45A
3ldwB-6b07A:42.7
3ldwB-6b07A:12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.36A
3ldwC-1rqjA:29.1
3ldwC-1rqjA:24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.48A
3ldwC-3q1oA:30.8
3ldwC-3q1oA:26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264
MG A 403 (-2.5A) MG A 403 (-2.4A)0MW A 404 (-2.7A)0MW A 404 (-3.7A)0MW A 404 (-2.8A)IPE A 405 ( 4.6A)0MW A 404 ( 3.8A) MG A 401 (-2.7A)0MW A 404 ( 3.0A)
0.56A
3ldwC-4e1eA:45.0
3ldwC-4e1eA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.49A
3ldwC-6b07A:43.3
3ldwC-6b07A:12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.30A
3ldwD-1rqjA:28.8
3ldwD-1rqjA:24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.46A
3ldwD-3q1oA:29.9
3ldwD-3q1oA:26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 98ASP A 102ARG A 107GLN A 167LYS A 207THR A 208GLN A 247ASP A 250LYS A 264
MG A 403 (-2.5A) MG A 403 (-2.4A)0MW A 404 (-2.7A)0MW A 404 (-3.7A)0MW A 404 (-2.8A)IPE A 405 ( 4.6A)0MW A 404 ( 3.8A) MG A 401 (-2.7A)0MW A 404 ( 3.0A)
0.47A
3ldwD-4e1eA:44.1
3ldwD-4e1eA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.44A
3ldwD-6b07A:42.3
3ldwD-6b07A:12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 182LEU A 255ILE A 299ARG A 302TRP A 314TYR A 323LEU A 341TYR A 427VAL A 444
NoneNoneDZW A 501 (-4.7A)DZW A 501 (-3.8A)DZW A 501 (-3.5A)DZW A 501 (-3.6A)NoneDZW A 501 (-4.9A)None
0.36A
3m7rA-6fobA:37.4
3m7rA-6fobA:22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 405LEU A 565ASN A 567PRO A 568THR A 579ILE A 582MET A 603GLN A 615PHE A 618
None9VE A 801 (-4.7A)9VE A 801 (-4.1A)9VE A 801 (-3.9A)9VE A 801 (-4.1A)9VE A 801 (-4.1A)9VE A 801 (-3.6A)9VE A 801 (-3.2A)9VE A 801 (-3.9A)
0.60A
3tvxA-5ohjA:54.7
3tvxA-5ohjA:13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 159LEU A 319ASN A 321PRO A 322THR A 333ILE A 336MET A 357GLN A 369PHE A 372
AKJ A 601 ( 4.7A)AKJ A 601 ( 4.6A)AKJ A 601 (-4.3A)AKJ A 601 (-3.9A)AKJ A 601 (-4.1A)AKJ A 601 (-3.8A)AKJ A 601 (-3.4A)AKJ A 601 (-3.0A)AKJ A 601 (-4.1A)
0.48A
3tvxA-5wh6A:52.3
3tvxA-5wh6A:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TRP A 81PRO A 82GLN A 85VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146MET A 149
NoneH1V A 501 (-4.6A)H1V A 501 ( 4.5A)H1V A 501 ( 4.4A)H1V A 501 (-4.2A)H1V A 501 (-4.7A)H1V A 501 (-3.2A)H1V A 501 (-3.8A)H1V A 501 ( 3.8A)
0.52A
4c66A-6dneA:23.4
4c66A-6dneA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 163HIS A 165HIS A 182VAL A 184VAL A 201LEU A 259THR A 260THR A 261TRP A 270
ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNoneNone ZN A 378 ( 4.5A)NoneNone
0.23A
4coqB-3b1bA:28.3
4coqB-3b1bA:28.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 117HIS A 119HIS A 136VAL A 138VAL A 148LEU A 201THR A 202THR A 203TRP A 212
ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNoneNone ZN A 301 (-4.4A)NoneNone
0.20A
4coqB-6ekiA:36.8
4coqB-6ekiA:23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199THR A 200TRP A 209
ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)NoneV14 A 302 (-3.6A)V14 A 302 (-3.2A)V14 A 302 (-3.5A)None
0.31A
4coqB-6fe1A:30.0
4coqB-6fe1A:18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASN A 141ALA A 143TYR A 145TYR A 171ASP A 173GLU A 212ASP A 214GLU A 217TRP A 367
BTB A 604 (-3.7A)BTB A 604 (-3.5A)BTB A 604 (-3.8A)NoneBTB A 604 (-3.7A)BTB A 604 (-2.7A)BTB A 604 ( 3.4A)BTB A 604 ( 3.0A)GOL A 607 ( 3.5A)
0.50A
4ipmA-5o5dA:61.9
4ipmA-5o5dA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASN A 142ALA A 144TYR A 146TYR A 170ASP A 172GLU A 196ASP A 198GLU A 201TRP A 320
ASN A 142 ( 0.6A)ALA A 144 ( 0.0A)TYR A 146 ( 1.3A)TYR A 170 ( 1.3A)ASP A 172 ( 0.5A)GLU A 196 ( 0.6A)ASP A 198 (-0.6A)GLU A 201 (-0.5A)TRP A 320 ( 0.5A)
0.55A
4ipmA-5w0aA:48.2
4ipmA-5w0aA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASN A 142ALA A 144TYR A 146TYR A 172ASP A 174GLU A 213ASP A 215GLU A 218TRP A 372
NoneNoneNoneNoneCTR A 506 ( 4.6A)CTR A 506 ( 4.5A)NoneCTR A 506 ( 4.3A)None
0.52A
4ipmA-5w11A:63.3
4ipmA-5w11A:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 102ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202GLN A 241ASP A 244LYS A 258
None MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.31A
4kfaA-1rqjA:30.0
4kfaA-1rqjA:25.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 89ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186GLN A 225ASP A 228LYS A 242
DMA A 501 ( 4.8A) MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.51A
4kfaA-3q1oA:31.0
4kfaA-3q1oA:27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 102ASP A 105ASP A 111ARG A 116LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
None MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.31A
4kpjA-1rqjA:29.9
4kpjA-1rqjA:26.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 89ASP A 92ASP A 98ARG A 103LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
DMA A 501 ( 4.8A) MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.51A
4kpjA-3q1oA:31.0
4kpjA-3q1oA:27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 77ASP A 80ASP A 86ARG A 91LYS A 178THR A 179GLN A 213ASP A 216LYS A 230
None CA A 304 ( 2.9A) CA A 305 (-2.3A)GST A 302 (-2.9A)GST A 302 (-3.4A)IPE A 301 (-4.2A)IPE A 301 ( 4.1A) CA A 303 (-2.9A)GST A 302 (-2.7A)
0.71A
4kpjA-4llsA:29.2
4kpjA-4llsA:29.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 102ASP A 105ASP A 111ARG A 116LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
None MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.38A
4nkfA-1rqjA:30.0
4nkfA-1rqjA:25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 89ASP A 92ASP A 98ARG A 103LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
DMA A 501 ( 4.8A) MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.51A
4nkfA-3q1oA:31.0
4nkfA-3q1oA:27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 77ASP A 80ASP A 86ARG A 91LYS A 178THR A 179GLN A 213ASP A 216LYS A 230
None CA A 304 ( 2.9A) CA A 305 (-2.3A)GST A 302 (-2.9A)GST A 302 (-3.4A)IPE A 301 (-4.2A)IPE A 301 ( 4.1A) CA A 303 (-2.9A)GST A 302 (-2.7A)
0.66A
4nkfA-4llsA:29.3
4nkfA-4llsA:29.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 102ASP A 105ASP A 111ARG A 116LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
None MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.35A
4oguA-1rqjA:29.7
4oguA-1rqjA:25.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 89ASP A 92ASP A 98ARG A 103LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
DMA A 501 ( 4.8A) MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.47A
4oguA-3q1oA:30.9
4oguA-3q1oA:27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LEU A 77ASP A 80ASP A 86ARG A 91LYS A 178THR A 179GLN A 213ASP A 216LYS A 230
None CA A 304 ( 2.9A) CA A 305 (-2.3A)GST A 302 (-2.9A)GST A 302 (-3.4A)IPE A 301 (-4.2A)IPE A 301 ( 4.1A) CA A 303 (-2.9A)GST A 302 (-2.7A)
0.70A
4oguA-4llsA:29.1
4oguA-4llsA:29.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 105ASP A 111ARG A 116GLN A 179LYS A 202THR A 203GLN A 241ASP A 244LYS A 258
MG A 907 (-2.5A) MG A 909 (-2.4A)RIS A 901 (-2.7A)RIS A 901 (-3.2A)RIS A 901 (-2.5A)IPE A 900 ( 3.3A)RIS A 901 ( 3.6A) MG A 908 ( 2.7A)RIS A 901 (-2.7A)
0.31A
4p0vA-1rqjA:31.2
4p0vA-1rqjA:27.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 92ASP A 98ARG A 103GLN A 163LYS A 186THR A 187GLN A 225ASP A 228LYS A 242
MG A 400 ( 2.8A) MG A 400 ( 3.2A)DMA A 501 (-3.0A)DMA A 501 (-3.6A)DMA A 501 (-3.1A)DMA A 500 (-3.4A)DMA A 501 ( 3.8A)DMA A 501 ( 3.5A)DMA A 501 (-2.7A)
0.48A
4p0vA-3q1oA:31.4
4p0vA-3q1oA:26.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ASP A 147ASP A 151ARG A 156GLN A 215LYS A 244THR A 245GLN A 284ASP A 287LYS A 301
MG A 402 (-2.6A) MG A 402 (-2.5A)C6M A 401 (-2.7A)C6M A 401 (-3.3A)C6M A 401 (-2.6A)C6M A 401 (-3.6A)C6M A 401 (-3.7A) MG A 404 ( 2.7A)C6M A 401 (-2.9A)
0.34A
4p0vA-6b07A:47.7
4p0vA-6b07A:14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 113HIS A 115HIS A 117HIS A 135VAL A 137LEU A 216THR A 217THR A 218TRP A 227
None ZN A 283 ( 3.2A) ZN A 283 (-3.2A) ZN A 283 ( 3.1A)ACY A 279 ( 4.7A)ACY A 279 (-4.3A)ACY A 279 (-3.4A)ACY A 279 ( 4.9A)None
0.40A
5jn8C-1y7wA:23.4
5jn8C-1y7wA:28.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 161HIS A 163HIS A 165HIS A 182VAL A 184LEU A 259THR A 260THR A 261TRP A 270
None ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNone ZN A 378 ( 4.5A)NoneNone
0.38A
5jn8C-3b1bA:24.3
5jn8C-3b1bA:25.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 87HIS A 89HIS A 91HIS A 108VAL A 110LEU A 173THR A 174THR A 175TRP A 184
AZM A 302 (-4.4A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)AZM A 302 (-4.7A)AZM A 302 (-3.8A)AZM A 302 (-3.4A)AZM A 302 (-3.4A)None
0.35A
5jn8C-4g7aA:27.7
5jn8C-4g7aA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 115HIS A 117HIS A 119HIS A 136VAL A 138LEU A 201THR A 202THR A 203TRP A 212
None ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNone ZN A 301 (-4.4A)NoneNone
0.37A
5jn8C-6ekiA:26.5
5jn8C-6ekiA:16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 92HIS A 94HIS A 96HIS A 119VAL A 121LEU A 198THR A 199THR A 200TRP A 209
V14 A 302 (-3.8A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)V14 A 302 (-3.6A)V14 A 302 (-3.2A)V14 A 302 (-3.5A)None
0.33A
5jn8C-6fe1A:32.4
5jn8C-6fe1A:16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 113HIS A 115HIS A 117HIS A 135VAL A 137LEU A 216THR A 217THR A 218TRP A 227
None ZN A 283 ( 3.2A) ZN A 283 (-3.2A) ZN A 283 ( 3.1A)ACY A 279 ( 4.7A)ACY A 279 (-4.3A)ACY A 279 (-3.4A)ACY A 279 ( 4.9A)None
0.33A
5jn9C-1y7wA:23.5
5jn9C-1y7wA:28.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 161HIS A 163HIS A 165HIS A 182VAL A 184LEU A 259THR A 260THR A 261TRP A 270
None ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNone ZN A 378 ( 4.5A)NoneNone
0.30A
5jn9C-3b1bA:24.3
5jn9C-3b1bA:25.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 87HIS A 89HIS A 91HIS A 108VAL A 110LEU A 173THR A 174THR A 175TRP A 184
AZM A 302 (-4.4A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)AZM A 302 (-4.7A)AZM A 302 (-3.8A)AZM A 302 (-3.4A)AZM A 302 (-3.4A)None
0.31A
5jn9C-4g7aA:27.7
5jn9C-4g7aA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 115HIS A 117HIS A 119HIS A 136VAL A 138LEU A 201THR A 202THR A 203TRP A 212
None ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNone ZN A 301 (-4.4A)NoneNone
0.30A
5jn9C-6ekiA:26.5
5jn9C-6ekiA:16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 92HIS A 94HIS A 96HIS A 119VAL A 121LEU A 198THR A 199THR A 200TRP A 209
V14 A 302 (-3.8A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)V14 A 302 (-3.6A)V14 A 302 (-3.2A)V14 A 302 (-3.5A)None
0.37A
5jn9C-6fe1A:32.4
5jn9C-6fe1A:16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 113HIS A 115HIS A 117HIS A 135VAL A 137LEU A 216THR A 217THR A 218TRP A 227
None ZN A 283 ( 3.2A) ZN A 283 (-3.2A) ZN A 283 ( 3.1A)ACY A 279 ( 4.7A)ACY A 279 (-4.3A)ACY A 279 (-3.4A)ACY A 279 ( 4.9A)None
0.34A
5jncC-1y7wA:23.4
5jncC-1y7wA:28.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 161HIS A 163HIS A 165HIS A 182VAL A 184LEU A 259THR A 260THR A 261TRP A 270
None ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNone ZN A 378 ( 4.5A)NoneNone
0.32A
5jncC-3b1bA:24.3
5jncC-3b1bA:25.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 87HIS A 89HIS A 91HIS A 108VAL A 110LEU A 173THR A 174THR A 175TRP A 184
AZM A 302 (-4.4A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)AZM A 302 (-4.7A)AZM A 302 (-3.8A)AZM A 302 (-3.4A)AZM A 302 (-3.4A)None
0.31A
5jncC-4g7aA:27.7
5jncC-4g7aA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 115HIS A 117HIS A 119HIS A 136VAL A 138LEU A 201THR A 202THR A 203TRP A 212
None ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNone ZN A 301 (-4.4A)NoneNone
0.32A
5jncC-6ekiA:26.5
5jncC-6ekiA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 92HIS A 94HIS A 96HIS A 119VAL A 121LEU A 198THR A 199THR A 200TRP A 209
V14 A 302 (-3.8A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)V14 A 302 (-3.6A)V14 A 302 (-3.2A)V14 A 302 (-3.5A)None
0.33A
5jncC-6fe1A:32.3
5jncC-6fe1A:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 113HIS A 115HIS A 117HIS A 135VAL A 137LEU A 216THR A 217THR A 218TRP A 227
None ZN A 283 ( 3.2A) ZN A 283 (-3.2A) ZN A 283 ( 3.1A)ACY A 279 ( 4.7A)ACY A 279 (-4.3A)ACY A 279 (-3.4A)ACY A 279 ( 4.9A)None
0.33A
5jncD-1y7wA:23.5
5jncD-1y7wA:28.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 161HIS A 163HIS A 165HIS A 182VAL A 184LEU A 259THR A 260THR A 261TRP A 270
None ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNone ZN A 378 ( 4.5A)NoneNone
0.30A
5jncD-3b1bA:24.1
5jncD-3b1bA:25.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 87HIS A 89HIS A 91HIS A 108VAL A 110LEU A 173THR A 174THR A 175TRP A 184
AZM A 302 (-4.4A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)AZM A 302 (-4.7A)AZM A 302 (-3.8A)AZM A 302 (-3.4A)AZM A 302 (-3.4A)None
0.27A
5jncD-4g7aA:27.5
5jncD-4g7aA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 115HIS A 117HIS A 119HIS A 136VAL A 138LEU A 201THR A 202THR A 203TRP A 212
None ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNone ZN A 301 (-4.4A)NoneNone
0.31A
5jncD-6ekiA:26.4
5jncD-6ekiA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 92HIS A 94HIS A 96HIS A 119VAL A 121LEU A 198THR A 199THR A 200TRP A 209
V14 A 302 (-3.8A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)V14 A 302 (-3.6A)V14 A 302 (-3.2A)V14 A 302 (-3.5A)None
0.33A
5jncD-6fe1A:32.0
5jncD-6fe1A:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 113HIS A 115HIS A 117HIS A 135VAL A 137LEU A 216THR A 217THR A 218TRP A 227
None ZN A 283 ( 3.2A) ZN A 283 (-3.2A) ZN A 283 ( 3.1A)ACY A 279 ( 4.7A)ACY A 279 (-4.3A)ACY A 279 (-3.4A)ACY A 279 ( 4.9A)None
0.39A
5ku6C-1y7wA:23.5
5ku6C-1y7wA:28.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 161HIS A 163HIS A 165HIS A 182VAL A 184LEU A 259THR A 260THR A 261TRP A 270
None ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNone ZN A 378 ( 4.5A)NoneNone
0.36A
5ku6C-3b1bA:24.3
5ku6C-3b1bA:25.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 87HIS A 89HIS A 91HIS A 108VAL A 110LEU A 173THR A 174THR A 175TRP A 184
AZM A 302 (-4.4A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)AZM A 302 (-4.7A)AZM A 302 (-3.8A)AZM A 302 (-3.4A)AZM A 302 (-3.4A)None
0.33A
5ku6C-4g7aA:27.7
5ku6C-4g7aA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 115HIS A 117HIS A 119HIS A 136VAL A 138LEU A 201THR A 202THR A 203TRP A 212
None ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNone ZN A 301 (-4.4A)NoneNone
0.34A
5ku6C-6ekiA:26.5
5ku6C-6ekiA:16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 92HIS A 94HIS A 96HIS A 119VAL A 121LEU A 198THR A 199THR A 200TRP A 209
V14 A 302 (-3.8A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)V14 A 302 (-3.6A)V14 A 302 (-3.2A)V14 A 302 (-3.5A)None
0.35A
5ku6C-6fe1A:32.4
5ku6C-6fe1A:16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 113HIS A 115HIS A 117HIS A 135VAL A 137LEU A 216THR A 217THR A 218TRP A 227
None ZN A 283 ( 3.2A) ZN A 283 (-3.2A) ZN A 283 ( 3.1A)ACY A 279 ( 4.7A)ACY A 279 (-4.3A)ACY A 279 (-3.4A)ACY A 279 ( 4.9A)None
0.38A
5ku6D-1y7wA:23.5
5ku6D-1y7wA:28.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 161HIS A 163HIS A 165HIS A 182VAL A 184LEU A 259THR A 260THR A 261TRP A 270
None ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNone ZN A 378 ( 4.5A)NoneNone
0.34A
5ku6D-3b1bA:24.2
5ku6D-3b1bA:25.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 87HIS A 89HIS A 91HIS A 108VAL A 110LEU A 173THR A 174THR A 175TRP A 184
AZM A 302 (-4.4A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)AZM A 302 (-4.7A)AZM A 302 (-3.8A)AZM A 302 (-3.4A)AZM A 302 (-3.4A)None
0.31A
5ku6D-4g7aA:27.5
5ku6D-4g7aA:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 115HIS A 117HIS A 119HIS A 136VAL A 138LEU A 201THR A 202THR A 203TRP A 212
None ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNone ZN A 301 (-4.4A)NoneNone
0.33A
5ku6D-6ekiA:26.4
5ku6D-6ekiA:16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLN A 92HIS A 94HIS A 96HIS A 119VAL A 121LEU A 198THR A 199THR A 200TRP A 209
V14 A 302 (-3.8A) ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)V14 A 302 (-3.6A)V14 A 302 (-3.2A)V14 A 302 (-3.5A)None
0.35A
5ku6D-6fe1A:32.0
5ku6D-6fe1A:16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45MET A 132ASP A 135ILE A 136VAL A 144GLN A 150
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.5A)TRP A 501 (-3.9A)NoneNoneTRP A 501 (-3.3A)
0.61A
5v0iA-6dfuA:45.7
5v0iA-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45MET A 132ASP A 135ILE A 136VAL A 144GLN A 150
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.5A)TRP A 501 (-3.9A)NoneNoneTRP A 501 (-3.3A)
0.61A
5v0iB-6dfuA:44.7
5v0iB-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
MET A 295ALA A 302GLU A 305LEU A 339MET A 340LEU A 343ARG A 346HIS A 475LEU A 476
EST A 601 ( 4.4A)EST A 601 ( 3.9A)EST A 601 (-2.4A)EST A 601 (-3.9A)EST A 601 ( 4.8A)EST A 601 ( 4.4A)EST A 601 (-4.1A)EST A 601 (-4.4A)EST A 601 (-3.5A)
0.31A
5wgdA-5toaA:31.7
5wgdA-5toaA:29.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 228MET A 249TYR A 260ASN A 262ARG A 267VAL A 269PHE A 324GLY A 336LYS A 346
ACT A 402 (-4.8A)NoneACT A 402 (-4.5A)ACT A 402 (-3.3A)ACT A 402 (-3.9A)NoneNoneNoneACT A 402 (-2.9A)
0.34A
5yjsB-5cadA:51.0
5yjsB-5cadA:13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.